Contents
- 1 Citation, commencement and interpretation
- 2 Amendment of article 4 of the principal Order
- 3 Amendment of Part I of Schedule 1 to the principal Order
- 4 Amendment of Table A of Part IV of Schedule 1 to the principal Order
- 5 Amendment of Schedule 3 to the principal Order
- The schedule Entries inserted in part I of schedule 3 to the principal order
Article 1Citation, commencement and interpretation#
(1)This Order may be cited as the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Amendment (No. 2) Order 1996 and shall come into force on 13th January 1997.
(2)In this Order “the principal Order” means the Medicines (Products Other Than Veterinary Drugs) (Prescription Only) Order 1983.
Article 2Amendment of article 4 of the principal Order#
In article 4 of the principal Order (medicinal products that are not prescription only)—
(a)in paragraph (1C) (mebendazole) for “400 milligrams” substitute “800 milligrams”;
(b)in paragraph (1N) (famotidine) for sub-paragraph (a) there is substituted the following sub-paragraph—“a the medicinal product is indicated for—i the short-term symptomatic relief of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity, orii the prevention of the symptoms of heartburn, dyspepsia, indigestion, acid indigestion or hyperacidity where they are associated with the consumption of food or drink, including the prevention of sleep disturbance due to those symptoms, and”
Article 3Amendment of Part I of Schedule 1 to the principal Order#
In Part I of Schedule 1 to the principal Order (which lists substances which render a medicinal product a prescription only medicine except in the circumstances also listed)—
(a)in Column 1—
(i)after the entry “Amygdalin” there is inserted the entry “Amyl Nitrite”,
(ii)after the entry “Argipressin” there are inserted the following entries—“AristolochiaAristolochia ClematitisAristolochia ContortaAristolochia DebelisAristolochia Fang-chiAristolochia ManshuriensisAristolochia Serpentaria”
(iii)for the entry “Lodoxomide Trometamol” there is substituted the entry “Lodoxamide Trometamol”,
(iv)after the entry “Tolmetin Sodium” there is inserted the entry “Trandolapril”,
(v)in the entry for Vaccines, after “Meningococcal Polysaccharide Vaccine” there is inserted “Mumps Vaccine”;
(b)in Column 3 in relation to Mebeverine Hydrocholoride there is inserted the following entry—“For the symptomatic relief of irritable bowel syndrome”
(c)in Column 4—
(i)for the entry relating to Mebeverine Hydrocholoride there is substituted the following entry—“135mg (MD)405mg (MDD)”
(ii)in the entry relating to Pseudoephedrine Hydrochloride for “90mg (MD)” there is substituted “120mg (MD)”.
Article 4Amendment of Table A of Part IV of Schedule 1 to the principal Order#
In Table A of Part IV of Schedule 1 to the principal Order (name and product licence number of medicinal products that are not prescription only medicines), the following entries are inserted at the appropriate points in the alphabetical order of the entries in that Table—“”
Article 5Amendment of Schedule 3 to the principal Order#
In Part I of Schedule 3 to the principal Order (exemptions for certain persons from the provisions of section 58(2)(a) of the Medicines Act 1968) at the end there are inserted the entries set out in the Schedule to this Order.
The schedule · Entries inserted in part I of schedule 3 to the principal order
Contains public sector information licensed under the Open Government Licence v3.0.